Compounds > reserpine
Page last updated: 2024-08-17

reserpine and norbinaltorphimine

reserpine has been researched along with norbinaltorphimine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brotchie, JM; Crossman, AR; Maneuf, YP; Mitchell, IJ; Woodruff, GN1
Brotchie, JM; Hill, MP1
Akao, Y; Arakawa, S; Fujisawa, M; Goto, K; Gotoh, A; Kamidono, S; Okada, H; Sasaki, H; Sengoku, A; Shirakawa, T1
Bernardi, G; D'Angelo, V; Lavaroni, F; Martella, G; Martorana, A; Spadoni, F; Stefani, A1

Other Studies

4 other study(ies) available for reserpine and norbinaltorphimine

ArticleYear
Functional implications of kappa opioid receptor-mediated modulation of glutamate transmission in the output regions of the basal ganglia in rodent and primate models of Parkinson's disease.
    Brain research, 1995, Jun-12, Volume: 683, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Arrhythmia Agents; Basal Ganglia; Benzofurans; Callithrix; Female; Glutamic Acid; In Vitro Techniques; Male; Motor Activity; Naltrexone; Parkinson Disease, Secondary; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reserpine; Synaptic Transmission

1995
The adrenergic receptor agonist, clonidine, potentiates the anti-parkinsonian action of the selective kappa-opioid receptor agonist, enadoline, in the monoamine-depleted rat.
    British journal of pharmacology, 1999, Volume: 128, Issue:7

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antiparkinson Agents; Benzofurans; Biogenic Monoamines; Clonidine; Disease Models, Animal; Drug Combinations; Drug Synergism; Locomotion; Male; Naltrexone; Narcotic Antagonists; Parkinson Disease, Secondary; Prazosin; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reserpine; Yohimbine

1999
Inhibition of urinary bladder motility by a spinal action of U-50488H in rats.
    The Journal of pharmacy and pharmacology, 2002, Volume: 54, Issue:12

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Area Under Curve; Dose-Response Relationship, Drug; Electric Stimulation; Injections, Intravenous; Injections, Spinal; Male; Methysergide; Muscle Contraction; Muscle, Smooth; Naltrexone; Pons; Rats; Rats, Wistar; Receptors, Opioid, kappa; Reserpine; Serotonin Antagonists; Stress, Mechanical; Urinary Bladder; Urination; Yohimbine

2002
Opioid-mediated modulation of calcium currents in striatal and pallidal neurons following reserpine treatment: focus on kappa response.
    Synapse (New York, N.Y.), 2004, Mar-01, Volume: 51, Issue:3

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adrenergic Uptake Inhibitors; Alkaloids; Analgesics, Non-Narcotic; Analgesics, Opioid; Analysis of Variance; Animals; Benzophenanthridines; Calcium Channel Blockers; Calcium Channels; Cell Size; Cells, Cultured; Corpus Striatum; Dose-Response Relationship, Drug; Drug Interactions; Dynorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine-2-Alanine; Enzyme Inhibitors; Male; Membrane Potentials; Naltrexone; Narcotic Antagonists; Neural Inhibition; Neurons; omega-Conotoxin GVIA; Patch-Clamp Techniques; Phenanthridines; Rats; Rats, Wistar; Receptors, Opioid, kappa; Reserpine

2004